Substituted [1,2,4]triazolo[1,5-a]pyrazines as spleen tyrosine kinase inhibitors
Grant
US12577248B2
Kind: B2
Mar 17, 2026
Assignee
NANJING RUIJIE PHARMA CO., LTD.
Inventors
Junbo Zhang, Shuhao Zhu, Xiaoxin Qi
Abstract
The present invention provides compounds of Formula (I) which can be used as Syk inhibitors and potently as therapeutic agents against diseases mediated by Syk.
CPC Classifications
A61K 31/4985
C07D 487/04
Filing Date
2021-05-28
Application No.
17928616
Claims
21